InVivo Therapeutics Holdings Balance Sheet Health
Financial Health criteria checks 4/6
InVivo Therapeutics Holdings has a total shareholder equity of $8.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $9.6M and $666.0K respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$8.58m |
| Equity | US$8.92m |
| Total liabilities | US$666.00k |
| Total assets | US$9.58m |
Recent financial health updates
Recent updates
InVivo Therapeutics dips 24% on $9M direct and private placement offerings
Oct 07We're Not Very Worried About InVivo Therapeutics Holdings' (NASDAQ:NVIV) Cash Burn Rate
Aug 26
Is InVivo Therapeutics Holdings (NASDAQ:NVIV) In A Good Position To Invest In Growth?
May 05Will InVivo Therapeutics Holdings (NASDAQ:NVIV) Spend Its Cash Wisely?
Jan 18Financial Position Analysis
Short Term Liabilities: NVIV.Q's short term assets ($9.5M) exceed its short term liabilities ($666.0K).
Long Term Liabilities: NVIV.Q has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: NVIV.Q is debt free.
Reducing Debt: NVIV.Q has no debt compared to 5 years ago when its debt to equity ratio was 1.2%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NVIV.Q has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: NVIV.Q has less than a year of cash runway if free cash flow continues to grow at historical rates of 11.3% each year.